FindTrial
Sign In

Clinical And Autoantibody Profile of Patients with Systemic Sclerosis

Clinical and autoantibody profile of patients of systemic sclerosis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/074418
Enrollment
20
Registered
2024-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M349- Systemic sclerosis, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients more than 12 years of age diagnosed with systemic sclerosis according to acr eular criteria of 2013

Exclusion criteria

Exclusion criteria: Smokers,Pregnant patient,Patient with Diabetes meliitus,Patient with Mixed connective tissue disorer and overlap syndrome

Design outcomes

Primary

MeasureTime frame
To determine the frequency, severity and patterns of interstitial lung disease in systemic sclerosis To document and analysis the frequency and severity of other organ involvement in systemic sclerosis viz. cutaneous, renal, cardiac, gastrointestinal and musculoskeletal To study the autoantibody profile of patients of systemic sclerosisTimepoint: 1 year—

Secondary

MeasureTime frame
To estimate the proportion of diffuse SSc versus limited SSc patients and differences in their clinical presentation and autoantibody profile To find out associations between clinical features and autoantibody profile in SSc patientsTimepoint: 1 year—

Countries

India

Contacts

Public ContactDipak Ramesh Mokariya

Maulana Azad Medical College

sumeetsingla555@gmail.com9810104431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026